Gamabufotalin suppresses pancreatic cancer through redox-homeostasis disruption by G6PD downregulation
Abstract Background Pancreatic cancer is a leading cause of cancer-related deaths worldwide, highlighting the critical need for novel therapeutic strategies. Gamabufotalin (CS-6), a bufadienolide compound, has been shown to exert significant inhibitory effects on a variety of cancers. Objective This...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2026-06-01
|
| Seri Bilgileri: | Journal of Translational Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12967-026-08441-2 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|